The findings demonstrate that Gene Ontology can be effectively leveraged for semantics-aware gene selection in clinical machine learning and offers a scalable strategy to uncover new, testable biological hypotheses–revealing gene functions that might otherwise remain hidden when examining only broadly selected gene combinations.
Abstract
The Gene Ontology (GO) is a public resource that describes gene functions and characteristics through a structured vocabulary of standardised terms. It currently contains annotations for over 1.5 million gene products, each linked to one or more GO terms. In this study, we propose integrating this GO-based semantic structure into machine learning systems for medical diagnostics. This approach serves a dual purpose: first, to prioritise genes that are semantically relevant to a given clinical task, thereby refining model input; and second, to enable the analysis of biologically predefined gene sets, which may reveal novel mechanisms underlying disease.
Evaluated across 16 benchmark data sets spanning diverse medical domains, our GO term-informed gene selection method generally outperformed models trained on full gene sets. Further analysis of individual GO terms not only enhanced classification performance but also identified high-performing, task-specific gene subsets that were overlooked during initial gene selection.
Our findings demonstrate that Gene Ontology can be effectively leveraged for semantics-aware gene selection in clinical machine learning. Moreover, systematically evaluating individual GO terms offers a scalable strategy to uncover new, testable biological hypotheses–revealing gene functions that might otherwise remain hidden when examining only broadly selected gene combinations.
LLMBDC (Large Language Model for Biological Domains Oriented Clustering of Gene Ontology) provides a scalable, reproducible, and interpretable route to context-aware, system-level interpretation of GO enrichment results while preserving biological specificity.
An embedding-based statistical framework is developed that transforms gene and function descriptions into vector representations, enabling statistical testing of gene-gene and gene-function relationships and quantitative prioritization of de novo functional hypotheses inferred by LLMs.
This work demonstrates how AI-driven informatics can enhance rare disease diagnosis and exemplifies the role of digital tools in transforming precision medicine and healthcare delivery.
J. Pérez-García, Federico García-Criado, F. Pazos et al.· iScience· 0 citations
Assessment of five small, open-source LLMs in identifying semantic relationships between biomedical concepts confirms that direct fine-tuning effectively exceeds the reasoning bottlenecks of smaller LLMs, providing an accurate, automated methodology for the construction and evolution of specialised biomedical ontologie...
Tanay Aggarwal, Angelo Salatino, Francesco Osborne et al.· arXiv.org· 0 citations
Benchmarks for rare-disease gene prioritisation are assembled from published clinical cases. Those cases often come from the same publications used to build knowledge-base (“curated”) tools, so a curated tool can be scored on its own source literature. This resource makes that circularity measurable. We release a strat...
Johanna Angulo, Héctor Espinós-Morató, Víctor Yeste· bioRxiv· 0 citations
This work presents a scalable, reproducible framework for evaluating, optimizing, and interpreting LLMs for biomedical knowledge extraction, with a focus on gene–gene regulatory relation prediction, pathway component recognition, multimodal pathway figure understanding, and automated prompt optimization.
Muhammad Azam· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.